Registrars: | Capita Registrars |
CEO: | Nigel Theobald |
Executive Director: | David Templeton |
Executive Director: | Luke Cairns |
Independent Non-Executive Director: | Alastair Smith |
Non-Executive Chairman: | Chris Britten |
Vice Chairman and CEO: | Michael Palfreyman |
Non-Executive Dir: |
Address: | 6th Floor, 60 Gracechurch Street, London, United Kingdom, EC3V 0HR |
Website: | http://www.n4pharma.com/ |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BYW8QM32 |
Currency | UK Pounds |
Share Price | 0.48p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 3.07p |
52 Week Low | 0.45p |
Volume | 2,985,780 |
Shares Issued | 832.28m |
Market Cap | £3.95m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:18 | 1,800,000 @ 0.47p |
15:30 | 1,050 @ 0.50p |
15:30 | 1,698 @ 0.50p |
12:01 | 1,073,718 @ 0.47p |
11:10 | 538 @ 0.50p |
You are here: research